190 related articles for article (PubMed ID: 9207371)
1. A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis.
Wilcox CM; Darouiche RO; Laine L; Moskovitz BL; Mallegol I; Wu J
J Infect Dis; 1997 Jul; 176(1):227-32. PubMed ID: 9207371
[TBL] [Abstract][Full Text] [Related]
2. A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasis.
Viljoen J; Azie N; Schmitt-Hoffmann AH; Ghannoum M
Antimicrob Agents Chemother; 2015 Mar; 59(3):1671-9. PubMed ID: 25561337
[TBL] [Abstract][Full Text] [Related]
3. Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
Barbaro G; Barbarini G; Di Lorenzo G
Chest; 1996 Dec; 110(6):1507-14. PubMed ID: 8989069
[TBL] [Abstract][Full Text] [Related]
4. Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Barbaro G; Barbarini G; Di Lorenzo G
Scand J Infect Dis; 1995; 27(6):613-7. PubMed ID: 8685642
[TBL] [Abstract][Full Text] [Related]
5. Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
Skiest DJ; Vazquez JA; Anstead GM; Graybill JR; Reynes J; Ward D; Hare R; Boparai N; Isaacs R
Clin Infect Dis; 2007 Feb; 44(4):607-14. PubMed ID: 17243069
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients.
Graybill JR; Vazquez J; Darouiche RO; Morhart R; Greenspan D; Tuazon C; Wheat LJ; Carey J; Leviton I; Hewitt RG; MacGregor RR; Valenti W; Restrepo M; Moskovitz BL
Am J Med; 1998 Jan; 104(1):33-9. PubMed ID: 9528717
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis.
Krause DS; Simjee AE; van Rensburg C; Viljoen J; Walsh TJ; Goldstein BP; Wible M; Henkel T
Clin Infect Dis; 2004 Sep; 39(6):770-5. PubMed ID: 15472806
[TBL] [Abstract][Full Text] [Related]
8. A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS.
Phillips P; De Beule K; Frechette G; Tchamouroff S; Vandercam B; Weitner L; Hoepelman A; Stingl G; Clotet B
Clin Infect Dis; 1998 Jun; 26(6):1368-73. PubMed ID: 9636865
[TBL] [Abstract][Full Text] [Related]
9. Fluconazole 150 mg single dose versus itraconazole 200 mg per day for 3 days in the treatment of acute vaginal candidiasis: a double-blind randomized study.
De Punzio C; Garutti P; Mollica G; Nappi C; Piccoli R; Genazzani AR
Eur J Obstet Gynecol Reprod Biol; 2003 Feb; 106(2):193-7. PubMed ID: 12551791
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis.
de Wet NT; Bester AJ; Viljoen JJ; Filho F; Suleiman JM; Ticona E; Llanos EA; Fisco C; Lau W; Buell D
Aliment Pharmacol Ther; 2005 Apr; 21(7):899-907. PubMed ID: 15801925
[TBL] [Abstract][Full Text] [Related]
11. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
Eichel M; Just-Nübling G; Helm EB; Stille W
Mycoses; 1996; 39 Suppl 1():102-6. PubMed ID: 8767280
[TBL] [Abstract][Full Text] [Related]
12. Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group.
de Repentigny L; Ratelle J
Chemotherapy; 1996; 42(5):374-83. PubMed ID: 8874977
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial: clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients.
Linpiyawan R; Jittreprasert K; Sivayathorn A
Int J Dermatol; 2000 Nov; 39(11):859-61. PubMed ID: 11123451
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.
Ally R; Schürmann D; Kreisel W; Carosi G; Aguirrebengoa K; Dupont B; Hodges M; Troke P; Romero AJ;
Clin Infect Dis; 2001 Nov; 33(9):1447-54. PubMed ID: 11577374
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of fluconazole suspension for the treatment of oesophageal candidiasis in patients with AIDS.
Laine L; Rabeneck L
Aliment Pharmacol Ther; 1995 Oct; 9(5):553-6. PubMed ID: 8580277
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis.
De Wit S; O'Doherty E; De Vroey C; Clumeck N
J Int Med Res; 1998; 26(3):159-70. PubMed ID: 9718471
[TBL] [Abstract][Full Text] [Related]
18. Comparative study on the effectiveness of antifungal agents in different regimens against vaginal candidiasis.
Mikamo H; Kawazoe K; Sato Y; Hayasaki Y; Tamaya T
Chemotherapy; 1998; 44(5):364-8. PubMed ID: 9732153
[TBL] [Abstract][Full Text] [Related]
19. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
[TBL] [Abstract][Full Text] [Related]
20. Management of chronic vulvovaginal candidiasis: a long term retrospective study.
Nguyen Y; Lee A; Fischer G
Australas J Dermatol; 2017 Nov; 58(4):e188-e192. PubMed ID: 27250078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
